428 related articles for article (PubMed ID: 35573838)
1. The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.
Moretto E; Stuart S; Surana S; Vargas JNS; Schiavo G
Front Cell Neurosci; 2022; 16():844211. PubMed ID: 35573838
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of secretion and spreading of pathological tau protein.
Brunello CA; Merezhko M; Uronen RL; Huttunen HJ
Cell Mol Life Sci; 2020 May; 77(9):1721-1744. PubMed ID: 31667556
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Jucker M; Walker LC
Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219
[TBL] [Abstract][Full Text] [Related]
4. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies.
Jo M; Lee S; Jeon YM; Kim S; Kwon Y; Kim HJ
Exp Mol Med; 2020 Oct; 52(10):1652-1662. PubMed ID: 33051572
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
6. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders.
Abramov AY; Berezhnov AV; Fedotova EI; Zinchenko VP; Dolgacheva LP
Biochem Soc Trans; 2017 Aug; 45(4):1025-1033. PubMed ID: 28733489
[TBL] [Abstract][Full Text] [Related]
7. Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved.
Vasili E; Dominguez-Meijide A; Outeiro TF
Front Mol Neurosci; 2019; 12():107. PubMed ID: 31105524
[TBL] [Abstract][Full Text] [Related]
8. Prion-like properties of assembled TDP-43.
Nonaka T; Hasegawa M
Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
[TBL] [Abstract][Full Text] [Related]
9. Brain clearance of protein aggregates: a close-up on astrocytes.
Giusti V; Kaur G; Giusto E; Civiero L
Mol Neurodegener; 2024 Jan; 19(1):5. PubMed ID: 38229094
[TBL] [Abstract][Full Text] [Related]
10. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 Prions.
Nonaka T; Hasegawa M
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein.
McAllister BB; Lacoursiere SG; Sutherland RJ; Mohajerani MH
Neurosci Biobehav Rev; 2020 May; 112():1-27. PubMed ID: 31996301
[TBL] [Abstract][Full Text] [Related]
13. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
[TBL] [Abstract][Full Text] [Related]
14. Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils.
Veys L; Van Houcke J; Aerts J; Van Pottelberge S; Mahieu M; Coens A; Melki R; Moechars D; De Muynck L; De Groef L
Front Aging Neurosci; 2020; 12():614587. PubMed ID: 33519421
[TBL] [Abstract][Full Text] [Related]
15. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
16. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
17. The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis.
Hanspal MA; Dobson CM; Yerbury JJ; Kumita JR
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2762-2771. PubMed ID: 28711596
[TBL] [Abstract][Full Text] [Related]
18. Cell-free amplification of prions: Where do we stand?
Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
